
Amadeus and Archimedia pump £1.6m into Qinec
Amadeus Capital Partners and Archimedia Investments have jointly backed medical technology company Qinec.
The web-based medical practice management business will use the new capital for development team expansion, particularly marketing and sales. Amadeus and Archimedia initially teamed up with Qinec in November 2011, but the bulk of the funding was done in November 2012 to complete the first round.
The backers sourced the deal through a personal network.
Company
Qinec is a cloud-based management platform for outpatient care, serving more than 1,000 clinicians with more than 1 million patients. The business caters to all classes including doctors, ophthalmologists and physiotherapists. Qinec currently has 100,000 patient records and, at the time of the investment, had signed on a blue-chip insurer and healthcare provider as a client. The business has distribution and licensing agreements internationally, including in the US.
The London-based business employs 28 people, including the management team. Products listed on the company's site are QinecTouch and QinecEnterprise.
People
Robbie Hughes is CEO of Qinec. John Hunt is founder and chairman of Archimedia, and Alex van Someren is managing partner of Amadeus Seed Fund.
Advisers
Equity (Amadeus) – Osborne Clarke (legal).
Equity (Archimedia) – Chadbourne & Parke (legal).
Management – Cannings Connolly (legal).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater